ATE95697T1 - Uricosuretische zusammensetzung. - Google Patents

Uricosuretische zusammensetzung.

Info

Publication number
ATE95697T1
ATE95697T1 AT88111996T AT88111996T ATE95697T1 AT E95697 T1 ATE95697 T1 AT E95697T1 AT 88111996 T AT88111996 T AT 88111996T AT 88111996 T AT88111996 T AT 88111996T AT E95697 T1 ATE95697 T1 AT E95697T1
Authority
AT
Austria
Prior art keywords
composition
uricosuretic
uricosuric
gout
chem
Prior art date
Application number
AT88111996T
Other languages
English (en)
Inventor
Mitsuyoshi Nakashima
Mitsutaka Kanamaru
Akira Sugiyama
Masato Terakawa
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of ATE95697T1 publication Critical patent/ATE95697T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
AT88111996T 1987-07-29 1988-07-26 Uricosuretische zusammensetzung. ATE95697T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18982287 1987-07-29
EP88111996A EP0301466B1 (de) 1987-07-29 1988-07-26 Uricosuretische Zusammensetzung

Publications (1)

Publication Number Publication Date
ATE95697T1 true ATE95697T1 (de) 1993-10-15

Family

ID=16247787

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88111996T ATE95697T1 (de) 1987-07-29 1988-07-26 Uricosuretische zusammensetzung.

Country Status (8)

Country Link
US (1) US4931440A (de)
EP (1) EP0301466B1 (de)
KR (1) KR960014874B1 (de)
AT (1) ATE95697T1 (de)
AU (1) AU615932B2 (de)
CA (1) CA1336959C (de)
DE (1) DE3884878T2 (de)
ZA (1) ZA885358B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0747582B2 (ja) * 1989-12-11 1995-05-24 杏林製薬株式会社 キナゾリン―３―アルカン酸誘導体とその塩およびその製造法
IL139071A0 (en) * 1999-02-18 2001-11-25 R Tech Ueno Ltd A composition containing an aldose reduction inhibitor for treatment of external secretion disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8524663D0 (en) * 1985-10-07 1985-11-13 Fujisawa Pharmaceutical Co Quinazoline derivatives

Also Published As

Publication number Publication date
EP0301466A3 (en) 1990-09-12
AU615932B2 (en) 1991-10-17
ZA885358B (en) 1989-03-29
CA1336959C (en) 1995-09-12
DE3884878T2 (de) 1994-02-17
DE3884878D1 (de) 1993-11-18
EP0301466B1 (de) 1993-10-13
AU2013888A (en) 1989-02-02
US4931440A (en) 1990-06-05
KR960014874B1 (ko) 1996-10-21
EP0301466A2 (de) 1989-02-01
KR890001555A (ko) 1989-03-27

Similar Documents

Publication Publication Date Title
NO912410L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklen-derivater.
ES8707947A1 (es) Un procedimiento para la preparacion de acidos 3-hidroxifenoxialquilenheterociclilcarboxilicos.
DK0453042T3 (da) Hidtil ukendte 2 9-disubstituerede 4H-pyhrido[1 2-a]pyridin-4-oner
NO163568C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater.
ATE145906T1 (de) Benzamid-derivate
NO166938C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoxyeddiksyrederivater.
ATE79257T1 (de) Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
ZA89389B (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
NO168243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO881835D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive bicykliske forbindelser.
DE69001722D1 (de) Entzuendungshemmende und/oder antiallergische zusammensetzung, die glutathionderivate enthaelt.
KR880007070A (ko) 백내장 치료용 약학 조성물
ATE38982T1 (de) Guanidinmethylcyclohexancarbonsaeure-derivate, verfahren zur herstellung und pharmazeutische mittel.
DE3884878D1 (de) Uricosuretische Zusammensetzung.
DK0420224T3 (da) Anthihepatopatisk middel
ATE81466T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee